Incidence and management of hepatic severe veno-occlusive disease in 273 patients in a single centre with defibrotide.
BMT Unit, Department of Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
R R
RR
Pol
BMT Unit, Department of Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
N
N
Russell
BMT Unit, Department of Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
E
E
Das-Gupta
BMT Unit, Department of Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
L
L
Watson
BMT Unit, Department of Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
L
L
Rachael
BMT Unit, Department of Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
J
J
Byrne
D000328:Adult; D000368:Aged; D019468:Disease Management; D005260:Female; D005343:Fibrinolytic Agents; D019337:Hematologic Neoplasms / Q000150:complications / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000401:mortality; D006504:Hepatic Veno-Occlusive Disease / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011089:Polydeoxyribonucleotides / Q000627:therapeutic use*; D016019:Survival Analysis
D005343:Fibrinolytic Agents; D011089:Polydeoxyribonucleotides; C036901:defibrotide